Russian Pharmaceutical Industry Leader
About
Products
Press center
R&D
Career
Antifraud
Export
Contacts
News
Media publications
Information materials
Terms of use
Home
Press center
News
Аll
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
LLC Bratskhimsyntez
Export
Аll
2024
2023
2022
2021
2020
2019
2018
2017
25.03.2021
Ambassador Extraordinary and Plenipotentiary of the Republic of India to the Russian Federation visited Pharmasyntez
Read more
23.03.2021
Pharmasyntez and SberBank held a joint press tour
Read more
22.01.2021
The first large-scale batch of Remdeform (INN Remdesivir) – the drug to treat COVID-19 – is ready for production at the Irkutsk Pharmasyntez plant
Read more
13.01.2021
Pharmasyntez implements the Skolkovo project
Read more
11.01.2021
VTB Leasing took part in the launch of the new plant of the Pharmasyntez Group in Tyumen
Read more
31.12.2020
New Year address from President of the Pharmasyntez Group of Companies
Read more
17.12.2020
JSC Pharmasyntez has commissioned the first plant in Primorye Territory for the production of medical face masks
Read more
15.12.2020
Russia as a Leader in the Fight against Tuberculosis
Read more
14.12.2020
A place for breakthrough ideas
Read more
04.12.2020
Pharmasyntez uses maximum production capacity for strengthening the fight against COVID-19
Read more
26.11.2020
Vladimir Putin and Denis Manturov opened a new pharmaceutical plant in Bratsk
Read more
12.11.2020
Vikram Punia on pharmaceutics in Russia and COVID-19 drug development
Read more
06.11.2020
Pharmasyntez will produce the COVID-19 Sputnik V vaccine
Read more
05.11.2020
Congratulations to Bioperitum on the victory!
Read more
15.10.2020
The 24th Russian Oncology Congress
Read more
14.10.2020
Sberbank will help to implement the strategy for the development of the pharmaceutical industry in Russia
Read more
News:
← предыдущая
7
8
9
10
11
следующая →
About
History
Production
JSC Pharmasyntez
LLC EAST-PHARM
LLC PHARMASYNTEZ-TYUMEN
JSC PHARMASYNTEZ-NORD
LLC BratskChemSyntez
Quality management
Management
Social projects
Products
Anti-TB
Antibiotics
Cardiology
Corticoid hormones
COVID-19
Drugs for the treatment of diabetes mellitus
Endocrinology
Gynecology
HIV treatment
Infusion solutions
Injectable solutions
Local anesthetic agents
MRI agents
Multiple sclerosis
Neuroleptics
Neurology
Nonsteroidal anti-inflammatory drug
Nootropics
Oncology
Systemic mycoses
Therapeutic drugs
Transplantology
Treatment of hepatitis B
X-ray contrast agents
Сообщить о нежелательном явлении
Заполнить анкету по качеству
Press center
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
LLC Bratskhimsyntez
Export
R&D
R&D co-operation
Intellectual property
Publications
Career
Personnel policy
Training and career development
Antifraud
Export
Possibilities
News
Contacts
Head office
Moscow Office
East-Pharm
Pharmasyntez-Tyumen
Pharmasyntez-Nord
BratskChemSyntez